beta
ABUS
Arbutus Biopharma Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
Market Cap: 292 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.arbutusbio.com
Shares Outstanding: 55.6 Million
Float: 51 Million
Dividend: 0.0 (0.0%)
Beta: 1.128171
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 705 Thousand
Ethical Flags
Longest drawdown: 1410 trading days
From: 2014-03-11 To: 2019-10-11
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|